Expertise in
7
conditions

Christophe Perrin

Nice, FR 
Expertise in
7
conditions
Nice, FR 

Overview

Christophe Perrin practices practicing medicine in Nice, France.

Mr. Perrin is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Fibromatosis, Polydactyly, Synovial Sarcoma, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 134 peer reviewed articles and participating in 13 clinical trials.

Gender

Male

Locations

Nice, France
Other Locations
Rennes, France
Paris, France
Nantes, France
Grasse, France
Cannes, France
GHE, Institut De Pathologie Est, Bron, France
Paris 14 Observatoire, France
Villeurbanne, France
Saint-etienne-de-valoux, 42055, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
A Randomized Phase II, Placebo-controlled, Multicenter Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Enrollment Status: Completed
Publish Date: July 21, 2026
Intervention Type: Drug
Study Drug: Regorafenib
Study Phase: Phase 2
Thromboembolic Risk Screening in Patients With Cancer and COVID-19
Thromboembolic Risk Screening in Patients With Cancer and COVID-19
Enrollment Status: Completed
Publish Date: July 01, 2026
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Enrollment Status: Completed
Publish Date: April 17, 2026
Intervention Type: Other
Study Phase: Phase 4
Efficacy of Regorafenib as Maintenance Therapy in Non-adipocytic Soft Tissue Sarcoma Having Received First-line Doxorubicin-based Chemotherapy
Efficacy of Regorafenib as Maintenance Therapy in Non-adipocytic Soft Tissue Sarcoma Having Received First-line Doxorubicin-based Chemotherapy
Enrollment Status: Completed
Publish Date: March 18, 2026
Intervention Type: Drug
Study Drug: Regorafenib
Study Phase: Phase 2
Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Enrollment Status: Completed
Publish Date: March 18, 2026
Intervention Type: Behavioral, Other
Study Phase: Not Applicable
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Phase I-II on Radiochemotherapy Combined With Panitumumab in the Treatment of Localised Epidermoid Carcinoma of the Anus
Phase I-II on Radiochemotherapy Combined With Panitumumab in the Treatment of Localised Epidermoid Carcinoma of the Anus
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drugs: Radiochemotherapy, Panitumumab
Study Phase: Phase 1/Phase 2
Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness
Frequency of Pompe's Disease and Neuromuscular Etiologies in Patients With Restrictive Respiratory Failure Associated With Signs of Muscle Weakness
Enrollment Status: Completed
Publish Date: March 22, 2023
Intervention Type: Other
Study Phase: Not Applicable
Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress
Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress
Enrollment Status: Completed
Publish Date: December 28, 2022
Intervention Type: Other
Study Phase: Not Applicable
Identification of the Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor of HR+ Metastatic Breast Cancer in Post-menopausal Women
Identification of the Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor of HR+ Metastatic Breast Cancer in Post-menopausal Women
Enrollment Status: Completed
Publish Date: September 21, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
View 9 Less Clinical Trials

134 Total Publications

Onychopapilloma Is a Nail Bed Onycholemmal Papilloma: A Clinical and Histological Study of 56 Cases, Including Seborrheic Keratosis-Like Lesions.
Onychopapilloma Is a Nail Bed Onycholemmal Papilloma: A Clinical and Histological Study of 56 Cases, Including Seborrheic Keratosis-Like Lesions.
Journal: The American Journal of dermatopathology
Published: April 21, 2026

Frequently Asked Questions about Christophe Perrin

Is Christophe Perrin a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Christophe Perrin is classified as an Distinguished expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christophe Perrin participate in research or clinical trials?

Yes. Christophe Perrin has published 134 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Christophe Perrin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Perrin's expertise for a condition
ConditionClose
    View All 44 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile